PB2175: NEXT-GENERATION SEQUENCING IN THE DIAGNOSIS, PROGNOSIS AND FEATURES OF THE COURSE OF THE DISEASE IN PATIENTS WITH PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

MLA

Anna Kirienko, et al. “Pb2175: Next-Generation Sequencing in the Diagnosis, Prognosis and Features of the Course of the Disease in Patients with Ph-Negative Myeloproliferative Neoplasms.” HemaSphere, vol. 7, Aug. 2023, p. e9529428. EBSCOhost, https://doi.org/10.1097/01.HS9.0000975452.95294.28.

APA

Anna Kirienko, Ekaterina Motyko, Daria Kustova, Vasiliy Shuvaev, Elizaveta Efremova, Sergey Sidorkevich, & Irina Martynkevich. (2023). Pb2175: Next-Generation Sequencing in the Diagnosis, Prognosis and Features of the Course of the Disease in Patients with Ph-Negative Myeloproliferative Neoplasms. HemaSphere, 7, e9529428. https://doi.org/10.1097/01.HS9.0000975452.95294.28

Chicago

Anna Kirienko, Ekaterina Motyko, Daria Kustova, Vasiliy Shuvaev, Elizaveta Efremova, Sergey Sidorkevich, and Irina Martynkevich. 2023. “Pb2175: Next-Generation Sequencing in the Diagnosis, Prognosis and Features of the Course of the Disease in Patients with Ph-Negative Myeloproliferative Neoplasms.” HemaSphere 7 (August): e9529428. doi:10.1097/01.HS9.0000975452.95294.28.